Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT05894265

Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

Led by The University of Texas Health Science Center, Houston · Updated on 2026-04-29

72

Participants Needed

1

Research Sites

163 weeks

Total Duration

On this page

Sponsors

T

The University of Texas Health Science Center, Houston

Lead Sponsor

S

Skye Biologics Holdings, LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery

CONDITIONS

Official Title

Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent form
  • Willingness to follow all study procedures and be available for the study duration
  • Have 1-2 full thickness reparable rotator cuff tendon tears
  • Definition of reparable tear: tendon can be moved back to the bone under minimal tension
  • Definition of full thickness tear: mostly supraspinatus and less than half infraspinatus involved with no significant subscapularis tear
  • Failed 4-6 weeks of physical therapy or guided home exercises and activity modification
  • No allergies or contraindications to the treatment
  • Have current shoulder imaging (X-rays and MRI) to exclude other causes
  • Able and willing to follow post-operative physical therapy and study follow-up
Not Eligible

You will not qualify if you...

  • Prior surgery on the affected shoulder within 12 months, including Latarjet, SLAP repair, or failed rotator cuff surgery
  • Prior bone defect surgery requiring implantation on the affected shoulder
  • Steroid injection in the affected shoulder within 6 weeks
  • Subscapularis tear involving more than one-third of the tendon needing repair
  • Calcific tendonitis in the affected shoulder
  • Fatty infiltration of rotator cuff muscles classified as Grade 3 or higher
  • Injury to the opposite shoulder that could affect rehabilitation
  • Advanced osteoarthritis of the shoulder joint (Grade 2 or higher)
  • History of cancer or bone metastases
  • History of abnormal bone growth (heterotopic ossification)
  • Chronic pain disorders such as fibromyalgia
  • Current substance abuse as judged by the investigator
  • For women of childbearing potential: unable/unwilling to use contraception, pregnant, breastfeeding, or planning pregnancy during the study
  • Currently or recently (within 30 days) enrolled in another similar study
  • Involved in injury litigation or workers compensation claims
  • Any condition the investigator believes would interfere with participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

E

Eric F Berkman, MD

CONTACT

L

Layla Haidar

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here